HIGHLIGHTS
- who: Nonfunctioning Pituitary Adenomas and collaborators from the Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China, Beijing have published the Article: A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas, in the Journal: (JOURNAL)
- what: The authors aimed to develop and validate a useful multi-lncRNA prediction model that may be used to evaluate recurrence and guide treatment after surgical resection in patients with NFPA. and 32 females, and the median follow-up was 76.5 months (range, 5-122). The local Ethics Committee approved this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.